Yeon-Christina

Christina H. Yeon, M.D.

  • Director of Infusion Services, City of Hope South Pasadena
  • Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
  • Medical Oncologist

Christina H. Yeon, M.D.

臨床專業領域
  • Medical Oncology
專業領域
  • Breast Cancer
研究重點
  • Breast Cancer
  • 2011 - present, Physician, Hematology/Oncology and Director of Infusion Services, City of Hope, South Pasadena, CA
  • 2004 - 2011, Physician, Wilshire Oncology Medical Group Inc., Pasadena, CA

地點

South Pasadena

209 Fair Oaks Avenue, South Pasadena, CA, 91030

獲取指示

電話 :  877-998-7546

學位

  • M.D.
  • 1998, UCLA, CA, awarded M.D.
  • 1994, UCLA, CA, Bachelor of Science, biochemistry, Summa Cum Laude

臨床研究醫師

  • 2001 -2004, Fellow, Hematology/Oncology, UCLA (University of California, Los Angeles), CA

住院醫師

  • 1999 -2001, Resident, Internal Medicine, UCLA, CA

實習

  • 1998 -1999, Intern, Internal Medicine, UCLA, CA
  • California State Medical License - Active
  • 2005, American Board of Internal Medicine - Subspecialty of Hematology
  • 2004, American Board of Internal Medicine - Subspecialty of Medical Oncology
  • 2001, American Board of Internal Medicine
G Upadhyaya, CA Presant, L Bosserman, A Estrella, A Greenburg, A Der, C Yeon, M Vakil, R Horns and B Ebrahimi. Wilshire Oncology Medical Group, La Verne, California. "Internet (Int) oncology (Onc) information (Inf) services: access and usage by oncology patients (pt) in 2006: the project for internet patient education (PIPE) program. Submitted, Amer Soc Clin Oncol, 2007.
 
C.A. Presant, L. Bosserman, C. Kelley, T. Young, M. Vakil, R. horns, G. Upadhyaya, B. Ebrahimi, H. Yeon, F. Howard and A. Rios. Wilshire Oncology Group, La Verne, California. "Aromatase inhibitor (AI)-associated arthralgia (A) and bone pain (BP): frequency and characterization in community based clinical practice." Proc Amer Soc Clin Oncol and Poster Presentation, 2006.
 
Cynthia L. Martel, MD, PhD, Cary A. Presant, MD, FACP, Ben Ebrahimi, MD, Gargi Upadhyaya, MD, Mayank Vakil, MD, Christina Yeon, MD, Linda D. Bosserman, MD, FACP, and Richard Horns, MD. "Bevacizumab-related toxicities: association of hypertension and proteinuria." Community Oncology 3(2):90-93, 2006.
 
Yeon CH and Pegram MD. Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer. Invest New Drugs 12(5): 391-409, 2005.; Bosserman LD, Horns RC, Presant CA, Vakil MJ, Upadhyaya GH, Martel CL, Ebrahimi B, Yeon CH. Development and Implementation of Effective Quality Guidelines in Community Cancer Centers: The Cancer Quality Program (CQP) [abstract]. Proc Amer Soc Clin Oncol 24, 2005.
 
Horns RC, Bosserman LD, Presant CA, Vakil MJ, Upadhyaya GH, Martel CL, Ebrahimi B, Yeon CH. Increasing Accrual to Clinical Trials in Community Cancer Centers: A Successful Method Using Electronic Medical Records [abstract]. Proc Amer Soc Clin Oncol 24, 2005.
 
Ebrahimi B, Martel B, Horns RC, Upadhyaya GH, Vakil MJ, Yeon CH, Bosserman LD and Presant CA. Heterogeneous Monitoring for and Management of Bevacizumab (BE) Toxicity (T): Development of Standardized Guidelines for Monitoring (mon) and Treatment (tre) of Bevacizumab Toxicity Syndrome (BETS) [abstract]. Proc Amer Soc Clin Oncol 24, 2005.
 
返回頂部